It’s been several months into the pandemic and still there is no evidenced-based drug that can fight back the deadly coronavirus. There is a need to follow precautionary measures to save yourself from catching the deadly COVID-19. However, primary and secondary schools closure in the United States has resulted in a significant reduction in the rate of deaths and newly infected cases of the severe acute respiratory syndrome coronavirus (SARS-CoV-2) in just two months, says a recent analysis conducted by experts from Cincinnati Children’s Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio. The findings of the study have been published in The Journal of American Medical Association (JAMA).
#ICYMI: COVID19 and School Closures – @KathyAugerpeds of @CincyChildrens and Julie Donohue, PhD of @PittPubHealth discuss policy options and the way forward for the 2020-21 school yearhttps://t.co/HOmR9GWIZd#JAMALive #OpenSchools
— JAMA (@JAMA_current) July 30, 2020
I am so excited to share the work of our incredible team. Association Between US Statewide School Closure and COVID-19 Incidence and Mortality in the US https://t.co/kaJug2M7WR via @JAMA_current @SamirShahMD @stats_hall @patrickwbrady @HartleyDM @JoThomsonMD @CincyPHM pic.twitter.com/y7OKpBnkkT
— Katherine Auger (@KathyAugerpeds) July 29, 2020
Due to a rapid increment in the cases infected people and the fatality rate of COVID-19, there is a need to follow every recommendation and instructions that are set by the medical health professionals from the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO).
School and closure of the other educational sectors are one of the major steps that have been taken by almost every nation around the world to stop the spread of the novel coronavirus that has made destruction around the entire globe.
The life-threatening virus has taken almost 671,000 lives and above 17 million cases are still running around the globe. As far as the concern goes to the USA, the virus has attacked the country on a devastating level by taking more than 150,000 lives and above 4.4 million people are still in a fight with the deadly coronavirus, according to data compiled by mixed resources including Coronavirus Resource Center by Johns Hopkins University (CRC: JHU) and Worldometer.
The current observational analysis has been conducted between March 9, 2020, and May 7, 2020, when the virus was on its peak. The study aimed to determine the differences among rates of deaths and newly infected cases of COVID-19. The sample of the study was based on the US population.
To find out the newly infected cases and fatality rate of the coronavirus, the used an interrupted time series analysis (ITSA) which is a statistical technique commonly used to track the meaningful statistics and other characteristics of the data before and after of an intervention point to check differences among the interventions.
To manage the before and after findings and state-level nonpharmaceutical interventions and attributes, the team used the negative binomial regression models (NB2) which are used to count variables. The aim of both of the analyses was to determine the overall mortality and infected cases of COVID-19 at the beginning of the school closure as well as those schools that remained open between two months.
At the time of school closure, there were an estimated 100,000 cases of COVID-19.
After the analysis, the team found out that there was a significant reduction in both fatalities (-58%) and infected cases (-62%) of COVID-19. The team also found a reduction of 128.7 and 1.5 per 100,000 cases of COVDI-19 in just 28 and over 16 days, respectively.
In just around two months, a significant decline in the incidence and death rate of the deadly coronavirus has been seen in the US-based population.
The current study has been funded by Agency for Healthcare Research and Quality awards Dr. Auger, Dr. Brady, Dr. Schondelmeyer, and Dr. Thomson and award from the National Center for Advancing Translational Sciences, National Institutes of Health.